Pfizer: Neoplasms trials
The registry lists 103 Neoplasms studies with Pfizer as lead sponsor. 2 are open to participants now and 56 have results posted.
Phase 1 69Phase 2 20Phase 3 8Phase 4 2No phase 7(a study in two phases counts in both)
Studies
Page 1 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight LossNot yet recruitingNCT07663630Phase 1
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatigueRecruitingNCT06989437Phase 2/3
- Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15CompletedNCT05546476Phase 2Results posted
- A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.CompletedNCT05228470Phase 2Results posted
- Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and AnorexiaCompletedNCT04803305Phase 1Results posted
- STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORSCompletedNCT04635631Phase 1Results posted
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT04607421Phase 3Results posted
- A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementTerminatedNCT04543188Phase 1Results posted
- Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.CompletedNCT04033991Results posted
- An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung CancerCompletedNCT03915951Phase 2Results posted
- Hepatic Impairment Study for Lorlatinib in Cancer PatientsTerminatedNCT03726333Phase 1Results posted
- Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsCompletedNCT03709680Phase 2Results posted
- A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)TerminatedNCT03472560Phase 2Results posted
- A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid TumorsCompletedNCT03343054Phase 1Results posted
- A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)CompletedNCT03289533Phase 1Results posted
- PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid TumorsTerminatedNCT03284723Phase 1Results posted
- Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS MutationCompletedNCT03271047Phase 2Results posted
- Open-Label Extension and Safety Study of TalazoparibCompletedNCT02921919Phase 2Results posted
- Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular LymphomaTerminatedNCT02855359Phase 2Results posted
- A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)CompletedNCT02684006Phase 3Results posted
- PF-06671008 Dose Escalation Study in Advanced Solid TumorsTerminatedNCT02659631Phase 1Results posted
- Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell LymphomaTerminatedNCT02592876Phase 2Results posted
- A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)CompletedNCT02493751Phase 1Results posted
- Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566CompletedNCT02315066Phase 1Results posted
- A Study Of PF-06647020 For Adult Patients With Advanced Solid TumorsCompletedNCT02222922Phase 1Results posted
- A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid TumorsTerminatedNCT02129205Phase 1Results posted
- A Study Of PF-06664178 In Patients With Advanced Solid TumorsTerminatedNCT02122146Phase 1Results posted
- A Study Of PF-06647263 In Patients With Advanced Solid TumorsTerminatedNCT02078752Phase 1Results posted
- Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLCCompletedNCT01945021Phase 2Results posted
- A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)CompletedNCT01920061Phase 1Results posted
- Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant MelanomaCompletedNCT01909453Phase 3Results posted
- A Study Of PF-06263507 In Patients With Advanced Solid TumorsTerminatedNCT01891669Phase 1Results posted
- A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast CancerCompletedNCT01684215Phase 2Results posted
- A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsCompletedNCT01525550Phase 4Results posted
- A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial CancerTerminatedNCT01420081Phase 2Results posted
- Asian Phase I Study Of PF-03446962CompletedNCT01337050Phase 1Results posted
- Risk of Cancer Among Pantoprazole UsersCompletedNCT01322633Results posted
- Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)TerminatedNCT01121588Phase 1Results posted
- A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To TumorsCompletedNCT01105533Phase 1Results posted
- Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With CancerCompletedNCT00942968Phase 4Results posted
- Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid TumorsCompletedNCT00940498Phase 1Results posted
- A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer PatientsCompletedNCT00927823Phase 1Results posted
- A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid TumorsTerminatedNCT00915278Phase 1Results posted
- Safety And PK Study Of CVX-060 In Patients With Advanced Solid TumorsCompletedNCT00879684Phase 1Results posted
- Open Label Extension In Cancer PatientsCompletedNCT00830180Phase 2Results posted
- A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid MalignanciesCompletedNCT00732992Phase 1Results posted
- A Study In Patients With Advanced Solid TumorCompletedNCT00726752Phase 1Results posted
- A Study of PF-04217903 in Patients With Advanced CancerTerminatedNCT00706355Phase 1Results posted
- Study Of Sunitinib Plus FOLFOX In Patients With Solid TumorsCompletedNCT00599924Phase 1Results posted
- A Study Of PF-03732010 In Patients With Advanced Solid TumorsCompletedNCT00557505Phase 1Results posted
- A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate CancerCompletedNCT00510718Phase 1Results posted
- Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorCompletedNCT00454649Phase 1Results posted
- A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.CompletedNCT00443534Not applicableResults posted
- PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With GemcitabineTerminatedNCT00437203Phase 1Results posted
- Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid TumorsCompletedNCT00195260Phase 1Results posted
- A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced CancerCompletedNCT00141297Phase 1Results posted
- Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid TumorsCompletedNCT00106353Phase 1/2Results posted
- Study Evaluating Temsirolimus (CCI-779) In Breast NeoplasmsCompletedNCT00062751Phase 2Results posted
- A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersTerminatedNCT06870487Phase 1
- A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.TerminatedNCT06546553Phase 1
- A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid TumorsTerminatedNCT06285097Phase 1
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsActive, not recruitingNCT05538130Phase 1
- Anticoagulation in Patients With Venous Thromboembolism and CancerCompletedNCT04618913
- Study of PF-07265807 in Participants With Metastatic Solid Tumors.TerminatedNCT04458259Phase 1
- A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple MyelomaTerminatedNCT03530683Phase 1
- Expanded Access Use of Tucatinib for HER2+ Metastatic Breast CancerNo longer availableNCT03424473
- Crizotinib Expanded Access Protocol For ROS1 Positive NSCLCNo longer availableNCT02824094
- Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric PatientsNo longer availableNCT02473497
- Safety Study of SEA-CD40 in Cancer PatientsTerminatedNCT02376699Phase 1
- A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)CompletedNCT02031991Phase 1
- A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01)CompletedNCT01603264Phase 1
- The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With CancerCompletedNCT01268163Phase 1
- Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)CompletedNCT01026415Phase 1
- Study Evaluating SKI-606 in Subject With Solid TumorsCompletedNCT01001936Phase 1
- A Trial Of SU14813 In Patients With Advanced Solid MalignanciesCompletedNCT00982267Phase 1
- A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid TumorsCompletedNCT00879554Phase 1
- A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid TumorsCompletedNCT00783328Phase 1
- Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy SubjectsCompletedNCT00777530Phase 1
- A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic CancerCompletedNCT00736372Phase 1
- Phase I Trial of Oral PX-866CompletedNCT00726583Phase 1
- A Study of ARRY-380 in Patients With Advanced HER2+ CancerCompletedNCT00650572Phase 1
- A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered TogetherCompletedNCT00618124Phase 1
- A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid TumorsCompletedNCT00615446Phase 1
- A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00528619Phase 1
- Phase I Trial of PX-478CompletedNCT00522652Phase 1
- Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00511849Phase 1
- Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer PatientsTerminatedNCT00492388Phase 3
- Phase II Study of PX-12 in Patients With Advanced Pancreatic CancerTerminatedNCT00417287Phase 2
- Study Evaluating MST-997 in Advanced Malignant Solid TumorsTerminatedNCT00277836Phase 1
- Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid TumorsTerminatedNCT00257881Phase 1
- Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid TumorsCompletedNCT00225121Phase 1
- Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.TerminatedNCT00195325Phase 1
- Study Evaluating TTI-237 in Advanced Malignant Solid TumorsTerminatedNCT00195247Phase 1
- Use of 852A in Metastatic Cutaneous Melanoma.CompletedNCT00189332Phase 2
- Study Evaluating CMD-193 in Advanced Malignant Solid TumorsCompletedNCT00161642Phase 1
- A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced CancerTerminatedNCT00147485Phase 1
- Study Evaluating MST-997 in Advanced Malignant Solid TumorsTerminatedNCT00088647Phase 1
- Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or LymphomaCompletedNCT00044759Phase 3
- Irinotecan in Treating Patients With Refractory Solid Tumors and Liver DysfunctionCompletedNCT00037804Phase 1
- Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00037791Phase 3